Pharma BD Deal Intelligence

Pharmacia Corporation / The Upjohn Company

1995 · Acquisition/Merger · $13.0B · Complete

Pharmacia AB and The Upjohn Company merged in a $13 billion merger of equals to create Pharmacia & Upjohn, headquartered in London. The cross-border deal combined Pharmacia's European strength with Upjohn's US commercial presence.

Key facts

• Announced Aug 20, 1995
• Closed Nov 02, 1995
• Deal value $13.0B
• Deal type Acquisition/Merger
• Therapeutic area Dermatology, Neurology, Oncology, Ophthalmology
• Indications Anxiety, Growth Hormone Deficiency, Alopecia
• Key assets Xanax (alprazolam), Rogaine (minoxidil), Genotropin (somatropin), Healon (hyaluronic acid)
• Mechanism Benzodiazepine, Potassium channel opener, Growth hormone

← Browse all deals  ·  How we score deals